(Q37253572)

19 August 2017

1 reference

title

Human autologous tumor-specific T cells in malignant melanoma (English)

1 reference

19 August 2017

Platsoucas CD

1

1 reference

19 August 2017

publication date

1 June 1991

1 reference

Cancer and Metastasis Reviews

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

151-176

1 reference

Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA.

19 August 2017

cites work

1 reference

12 December 2020

H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide

1 reference

12 December 2020

Enhancement of cytotoxic and proliferative responses of lymphocytes from melanoma patients by incubation with monoclonal antibodies against ganglioside GD3

1 reference

12 December 2020

γ/δ T cell antigen receptors expressed on tumor‐infiltrating lymphocytes from patients with solid tumors

1 reference

12 December 2020

Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence

1 reference

12 December 2020

Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.

1 reference

12 December 2020

Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck

1 reference

12 December 2020

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

12 December 2020

Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.

1 reference

12 December 2020

Depletion of T-cells with the CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma

1 reference

12 December 2020

Inhibition of interleukin 2 production by factors released from tumor cells.

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones

1 reference

12 December 2020

Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy

1 reference

12 December 2020

Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer ce

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Stimulation of anti-influenza cytolytic T lymphocytes by CNBr cleavage fragments of the viral hemagglutinin.

1 reference

12 December 2020

Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis

1 reference

12 December 2020

Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells

1 reference

12 December 2020

Human tumor-lymphocyte interactionin vitro. III. T lymphocytes in autologous tumor stimulation (ATS)

1 reference

12 December 2020

Spontaneous human T-cell cytotoxicity against murine hybridomas expressing the OKT3 monoclonal antibody: comparison with natural killer cell activity

1 reference

12 December 2020

Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity

1 reference

12 December 2020

In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin

1 reference

12 December 2020

Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens

1 reference

12 December 2020

CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production

1 reference

12 December 2020

Production of stable cytolytic T-cell clones directed against autologous human melanoma

1 reference

12 December 2020

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

12 December 2020

The delta TCS1 determinant is expressed on both disulfide- and non-disulfide-linked gamma delta T-cell antigen receptors

1 reference

12 December 2020

Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements

1 reference

12 December 2020

Localization of an immunorecessive epitope on SV40 T antigen by H-2Db-restricted cytotoxic T-lymphocyte clones and a synthetic peptide

1 reference

12 December 2020

Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma

1 reference

12 December 2020

In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma

1 reference

12 December 2020

Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses

1 reference

12 December 2020

Activation of human peripheral blood mononuclear cells by anti-T3: killing of tumor target cells coated with anti-target-anti-T3 conjugates

1 reference

12 December 2020

Separation and growth of human CD4+ and CD8+ tumor-infiltrating lymphocytes and peripheral blood mononuclear cells by direct positive panning on covalently attached monoclonal antibody-coated flasks

1 reference

12 December 2020

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response

1 reference

12 December 2020

Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

1 reference

12 December 2020

Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+.

1 reference

12 December 2020

Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes

1 reference

12 December 2020

Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2

1 reference

12 December 2020

Cytotoxic T cells recognize fragments of the influenza nucleoprotein

1 reference

12 December 2020

Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma

1 reference

12 December 2020

T-cell gene rearrangements and the diagnosis of T-cell neoplasms.

1 reference

12 December 2020

Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector-target cell binding and of the T3/Leu 4 antigen with triggering

1 reference

12 December 2020

Infiltrating lymphocytes in benign and malignant naevomelanocytic lesions

1 reference

12 December 2020

Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes

1 reference

12 December 2020

In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.

1 reference

12 December 2020

Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay

1 reference

12 December 2020

Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes

1 reference

12 December 2020

T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response

1 reference

12 December 2020

Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope

1 reference

12 December 2020

Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions

1 reference

12 December 2020

Lack of correlation between peripheral blood lymphokine-activated killer (LAK) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2.

1 reference

12 December 2020

Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures

1 reference

12 December 2020

Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

1 reference

12 December 2020

The role of T cell differentiation markers in antigen-specific and lectin-dependent cellular cytotoxicity mediated by T8+ and T4+ human cytotoxic T cell clones directed at class I and class II MHC antigens

1 reference

12 December 2020

Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man

1 reference

12 December 2020

Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction

1 reference

12 December 2020

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

1 reference

12 December 2020

Antigenic Tumor Cell Variants Obtained with Mutagens

1 reference

12 December 2020

Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients

1 reference

12 December 2020

Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.

1 reference

12 December 2020

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele

1 reference

12 December 2020

Inhibition of the growth of human melanoma xenografts in nude mice by human tumor-specific cytotoxic T-cells

1 reference

12 December 2020

Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes

1 reference

12 December 2020

Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells

1 reference

12 December 2020

Suppressor cell activity in melanoma patients. I. Relation to tumor growth an immunoglobulin levels in vivo

1 reference

12 December 2020

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

1 reference

12 December 2020

Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide

1 reference

12 December 2020

Tumor-specific cytolysis by lymphocytes infiltrating human melanomas

1 reference

12 December 2020

Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells

1 reference

12 December 2020

Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.

1 reference

12 December 2020

Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi

1 reference

12 December 2020

Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes

1 reference

12 December 2020

Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas.

1 reference

12 December 2020

Human T cells specifically activated against autologous malignant melanoma

1 reference

12 December 2020

DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization

1 reference

12 December 2020

The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens

1 reference

12 December 2020

Suppressor cell activity in melanoma-draining lymph nodes

1 reference

12 December 2020

Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells

1 reference

12 December 2020

Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line

1 reference

12 December 2020

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma

1 reference

12 December 2020

Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytes choriomeningitis

1 reference

12 December 2020

HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes

1 reference

12 December 2020

Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells

1 reference

12 December 2020

Inhibition of specific cell-mediated cytotoxicity by monoclonal antibodies to human T cell antigens

1 reference

12 December 2020

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes

1 reference

12 December 2020

Specific binding and lysis of human melanoma by IL-2-activated cells coated with anti-T3 or anti-Fc receptor cross-linked to antimelanoma antibody: a possible approach to the immunotherapy of human tumors

1 reference

12 December 2020

Presence on a human melanoma of multiple antigens recognized by autologous CTL.

1 reference

12 December 2020

Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures

1 reference

12 December 2020

The Clinical Diagnosis, Classification and Histogenetic Concepts of the Early Stages of Cutaneous Malignant Melanomas

1 reference

12 December 2020

Review of interleukin-2 alone and interleukin-2/LAK clinical trials in metastatic malignant melanoma

1 reference

12 December 2020

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor

1 reference

12 December 2020

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

1 reference

12 December 2020

Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity

1 reference

12 December 2020

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis

1 reference

12 December 2020

Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

1 reference

12 December 2020

Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine

1 reference

12 December 2020

Culture of human tumor infiltrating lymphocytes in hollow fiber bioreactors

1 reference

12 December 2020

Differential regulation by interleukin-4 and interferon-gamma of an autologous melanoma-specific cytotoxic T-cell clone and the tumor-infiltrating lymphocytes from which it was established

1 reference

12 December 2020

Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas

1 reference

12 December 2020

Histological evidence of natural killer cell aggregation against malignant melanoma induced by adoptive immunotherapy with lymphokine-activated killer cells

1 reference

12 December 2020

Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response

1 reference

12 December 2020

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

1 reference

12 December 2020

Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells

1 reference

12 December 2020

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

1 reference

12 December 2020

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

1 reference

12 December 2020

Developmentally regulated rearrangement and expression of genes encoding the T cell receptor-T3 complex

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

1 reference

12 December 2020

Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin

1 reference

12 December 2020

Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy

1 reference

12 December 2020

Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.

1 reference

12 December 2020

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

12 December 2020

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

1 reference

12 December 2020

Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.

1 reference

12 December 2020

Inhibition of human tumor growth by IgG2A monoclonal antibodies correlates with antibody density on tumor cells

1 reference

12 December 2020

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

1 reference

12 December 2020

Histology and prognosis in malignant melanoma

1 reference

12 December 2020

Clonal analysis of cytotoxic T cell response against human melanoma

1 reference

12 December 2020

The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens

1 reference

12 December 2020

Western blot analysis of antigens on melanoma cells recognized by cytotoxic T cells

1 reference

12 December 2020

Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.

1 reference

12 December 2020

Comparative studies of the long-term growth of lymphocytes from tumor infiltrates, tumor-draining lymph nodes, and peripheral blood by repeated in vitro stimulation with autologous tumor

1 reference

12 December 2020

Isolation and characterization of antigen-la complexes involved in T cell recognition

1 reference

12 December 2020

Proliferative and/or cytotoxic activity of lymphocyte clones to autologous human melanoma

1 reference

12 December 2020

Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside

1 reference

12 December 2020

Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.

1 reference

12 December 2020

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice

1 reference

12 December 2020

A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.

1 reference

12 December 2020

Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen

1 reference

12 December 2020

H-2 dependence of co-operation between T and B cells in vivo.

1 reference

12 December 2020

Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes

1 reference

12 December 2020

Human monoclonal antibodies: prospects for the therapy of cancer

1 reference

12 December 2020

Autologous lymph node cell-derived tumor-specific cytotoxic T-cells for use in adoptive immunotherapy of human melanoma

1 reference

12 December 2020

Structure of the human class I histocompatibility antigen, HLA-A2

1 reference

12 December 2020

Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens

1 reference

12 December 2020

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens

1 reference

12 December 2020

The use of microcapsules for high density growth of human tumor infiltrating lymphocytes and other immune reactive T cells

1 reference

12 December 2020

Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

1 reference

12 December 2020

Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas

1 reference

12 December 2020

Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases

1 reference

12 December 2020

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

1 reference

12 December 2020

Activated lymphocyte killer cells derived from melanoma tissue or peripheral blood

1 reference

12 December 2020

T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis

1 reference

12 December 2020

Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells

1 reference

12 December 2020

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

1 reference

12 December 2020

Implications of leukoregulin to autologous tumor-specific human T-cell populations

1 reference

12 December 2020

Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones.

1 reference

12 December 2020

Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma

1 reference

12 December 2020

Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes.

1 reference

12 December 2020

Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.

1 reference

12 December 2020

Isolation and characterization of a CNBr cleavage peptide of influenza viral hemagglutinin stimulatory for mouse cytolytic T lymphocytes

1 reference

12 December 2020

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

12 December 2020

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides

1 reference

12 December 2020

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

12 December 2020

Hormone conjugated with antibody to CD3 mediates cytotoxic T cell lysis of human melanoma cells

1 reference

12 December 2020

Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing

1 reference

12 December 2020

Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.

1 reference

12 December 2020

Functional characterization of T lymphocytes propagated from human lung carcinomas

1 reference

12 December 2020

Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex

1 reference

12 December 2020

Expression of Ia-like antigens on cultured human malignant melanoma cell lines

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00049412

1 reference

19 August 2017

1 reference